X-112671342-G-A
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The ENST00000371968.8(LHFPL1):c.49C>T(p.Leu17Phe) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000174 in 1,210,308 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 4 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 13/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
ENST00000371968.8 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
LHFPL1 | NM_178175.4 | c.49C>T | p.Leu17Phe | missense_variant | 2/4 | ENST00000371968.8 | NP_835469.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
LHFPL1 | ENST00000371968.8 | c.49C>T | p.Leu17Phe | missense_variant | 2/4 | 1 | NM_178175.4 | ENSP00000361036 | P1 | |
LHFPL1 | ENST00000478229.1 | n.226+8487C>T | intron_variant, non_coding_transcript_variant | 3 |
Frequencies
GnomAD3 genomes AF: 0.0000267 AC: 3AN: 112221Hom.: 0 Cov.: 23 AF XY: 0.0000291 AC XY: 1AN XY: 34391
GnomAD3 exomes AF: 0.0000872 AC: 16AN: 183419Hom.: 0 AF XY: 0.0000442 AC XY: 3AN XY: 67871
GnomAD4 exome AF: 0.0000164 AC: 18AN: 1098034Hom.: 0 Cov.: 31 AF XY: 0.00000826 AC XY: 3AN XY: 363388
GnomAD4 genome AF: 0.0000267 AC: 3AN: 112274Hom.: 0 Cov.: 23 AF XY: 0.0000290 AC XY: 1AN XY: 34454
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | May 18, 2023 | The c.49C>T (p.L17F) alteration is located in exon 2 (coding exon 1) of the LHFPL1 gene. This alteration results from a C to T substitution at nucleotide position 49, causing the leucine (L) at amino acid position 17 to be replaced by a phenylalanine (F). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at